New research strategies in retrope ... | Article | H1 Connect
[Review / Commentary]
van Houdt WJ et al.
Current Opinion in Oncology. 2019 07; 31(4):310-316
https://doi.org/10.1097/CCO.0000000000000535PMID: 30893150Evaluations
Evidence for the use of preoperative chemotherapy for high-grade retroperitoneal (RP) soft tissue sarcoma (STS) is often extrapolated from studies of extremity and trunk STS. This article provides a useful guide to new approaches in researching this disease, highlighting that the planned STRASS 2 trial (EORTC 1809) will directly assess the role of preoperative chemotherapy in RP STS, with results for this important trial anticipated in 2028.
This Recommendation is of an article referenced in a Faculty Review also written by Richard Riedel.
Relevant Specialties
Oncology
Sarcomas